{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:42:45Z","timestamp":1790700165212,"version":"4.1.0"},"reference-count":76,"publisher":"The Endocrine Society","issue":"2","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SUN22G0-CFRD"],"award-info":[{"award-number":["SUN22G0-CFRD"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK090490"],"award-info":[{"award-number":["R01DK090490"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diabetes can occur secondary to a wide array of exocrine pancreas pathologies. Pancreatogenic diabetes is a broad diagnostic term used to encompass these disparate causes of diabetes, which taken together are estimated to account for 1% to 9% of all cases of diabetes. The more common causes of pancreatogenic diabetes include pancreatitis, pancreatic ductal adenocarcinoma, cystic fibrosis, pancreatectomy, and fibrocalculous pancreatic disease. Persons with these exocrine pancreatic conditions should be screened for diabetes. Reciprocally, clinicians should consider the possibility of underlying pancreatic disease in persons with diabetes. Of special concern, diabetes can be the presenting sign of pancreatic ductal adenocarcinoma, for which clinical suspicion remains crucial as there are not yet distinguishing biomarkers. Timely diagnosis of diabetes is especially important in cystic fibrosis, because even mild diabetes can worsen lung disease and mortality risk in this condition. Exocrine pancreatic insufficiency is present in many cases of pancreatogenic diabetes. In these cases, provision of pancreatic enzyme replacement therapy may improve glycemic control. Optimal screening and treatment approaches are evolving, differing depending on the specific pancreatic pathology. Clinicians should be vigilant for exocrine pancreas symptomatology, including abdominal pain, steatorrhea, and malabsorption in their patients with diabetes.<\/jats:p>","DOI":"10.1210\/clinem\/dgaf623","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T12:52:49Z","timestamp":1763470369000},"page":"e569-e576","source":"Crossref","is-referenced-by-count":7,"title":["Approach to the Patient With Pancreatogenic Diabetes"],"prefix":"10.1210","volume":"111","author":[{"given":"Katie Larson","family":"Ode","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Diabetes, Department of Pediatrics, University of Iowa , Iowa City, IA 52242 ,","place":["USA"]},{"name":"Fraternal Order of Eagles Diabetes Research Center, University of Iowa , Iowa City, IA 52242 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5046-4223","authenticated-orcid":false,"given":"Yumi","family":"Imai","sequence":"additional","affiliation":[{"name":"Fraternal Order of Eagles Diabetes Research Center, University of Iowa , Iowa City, IA 52242 ,","place":["USA"]},{"name":"Department of Internal Medicine, Carver College of Medicine, University of Iowa , Iowa City, IA 52242 ,","place":["USA"]},{"name":"Endocrinology Section, Iowa City Veterans Affairs Medical Center , Iowa City, IA 52246 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8396-9543","authenticated-orcid":false,"given":"Andrew W","family":"Norris","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Diabetes, Department of Pediatrics, University of Iowa , Iowa City, IA 52242 ,","place":["USA"]},{"name":"Fraternal Order of Eagles Diabetes Research Center, University of Iowa , Iowa City, IA 52242 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"Suppl 1","key":"2026012101523848600_dgaf623-B1","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc25-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","journal-title":"Diabetes Care"},{"issue":"3","key":"2026012101523848600_dgaf623-B2","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2468-1253(16)30106-6","article-title":"Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer","volume":"1","author":"Hart","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026012101523848600_dgaf623-B3","volume-title":"Classification of Diabetes mellitus","author":"World Health Organization","year":"2019"},{"issue":"11","key":"2026012101523848600_dgaf623-B4","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2337\/dc17-0542","article-title":"Incidence, demographics, and clinical characteristics of diabetes of the exocrine pancreas (type 3c): a retrospective cohort study","volume":"40","author":"Woodmansey","year":"2017","journal-title":"Diabetes Care"},{"issue":"1618","key":"2026012101523848600_dgaf623-B5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/bmj.1.1618.9","article-title":"Remarks on two cases of pancreatic diabetes: the one exceptionally acute, the other markedly chronic","volume":"1","author":"Harley","year":"1892","journal-title":"Br Med J"},{"issue":"5","key":"2026012101523848600_dgaf623-B6","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/MPA.0000000000001818","article-title":"Identification of a risk profile for new-onset diabetes after acute pancreatitis","volume":"50","author":"Firkins","year":"2021","journal-title":"Pancreas"},{"issue":"1","key":"2026012101523848600_dgaf623-B7","doi-asserted-by":"crossref","first-page":"46","DOI":"10.2337\/dc22-1414","article-title":"Development of a clinical prediction model for diabetes in chronic pancreatitis: the PREDICT3c study","volume":"46","author":"Jeon","year":"2023","journal-title":"Diabetes Care"},{"issue":"5","key":"2026012101523848600_dgaf623-B8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/MOG.0000000000000756","article-title":"Diabetes in chronic pancreatitis: risk factors and natural history: risk factors and natural history","volume":"37","author":"Goodarzi","year":"2021","journal-title":"Curr Opin Gastroenterol"},{"issue":"5","key":"2026012101523848600_dgaf623-B9","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/MPG.0000000000003590","article-title":"Analysis of INSPPIRE-2 cohort: risk factors and disease burden in children with acute recurrent or chronic pancreatitis","volume":"75","author":"Uc","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"19","key":"2026012101523848600_dgaf623-B10","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJM196911062811902","article-title":"L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease","volume":"281","author":"Haskell","year":"1969","journal-title":"N Engl J Med"},{"issue":"10252","key":"2026012101523848600_dgaf623-B11","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(20)31310-6","article-title":"Acute pancreatitis","volume":"396","author":"Boxhoorn","year":"2020","journal-title":"Lancet"},{"key":"2026012101523848600_dgaf623-B12","volume-title":"StatPearls","author":"Klochkov","year":"2025"},{"issue":"5","key":"2026012101523848600_dgaf623-B13","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/jgh.16906","article-title":"The global, regional, and national burden of pancreatitis from 1990 to 2021: a systematic analysis for the global burden of disease study 2021","volume":"40","author":"Zhou","year":"2025","journal-title":"J Gastroenterol Hepatol"},{"key":"2026012101523848600_dgaf623-B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2025.03.008","article-title":"How alcohol induces human acute alcoholic pancreatitis-problem solved?","author":"Nordback","year":"2025","journal-title":"Am J Pathol"},{"issue":"1","key":"2026012101523848600_dgaf623-B15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4291\/wjgp.v7.i1.48","article-title":"Alcoholic pancreatitis: new insights into the pathogenesis and treatment","volume":"7","author":"Clemens","year":"2016","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"1","key":"2026012101523848600_dgaf623-B16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ueg2.12741","article-title":"Chronic and idiopathic pancreatitis-A personalized treatment approach","volume":"13","author":"von Widdern","year":"2025","journal-title":"United European Gastroenterol J"},{"issue":"10","key":"2026012101523848600_dgaf623-B17","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.5005\/jp-journals-10071-23988","article-title":"Differential diagnosis of ketoacidosis in hyperglycemic alcoholic diabetic patient: role of insulin","volume":"25","author":"Garg","year":"2021","journal-title":"Indian J Crit Care Med"},{"key":"2026012101523848600_dgaf623-B18","volume-title":"StatPearls","author":"Howard","year":"2025"},{"key":"2026012101523848600_dgaf623-B19","volume-title":"Endotext","author":"Feingold","year":"2000"},{"issue":"7","key":"2026012101523848600_dgaf623-B20","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3390\/jcm13072028","article-title":"Acute pancreatitis during and after pregnancy: a review","volume":"13","author":"Maringhini","year":"2024","journal-title":"J Clin Med"},{"issue":"6","key":"2026012101523848600_dgaf623-B21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11892-020-01299-8","article-title":"Diabetes of the exocrine pancreas related to hereditary pancreatitis, an update","volume":"20","author":"Ramalho","year":"2020","journal-title":"Curr Diab Rep"},{"issue":"9","key":"2026012101523848600_dgaf623-B22","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41395-018-0194-5","article-title":"Hereditary pancreatitis in the United States: survival and rates of pancreatic cancer","volume":"113","author":"Shelton","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"2026012101523848600_dgaf623-B23","doi-asserted-by":"crossref","first-page":"974","DOI":"10.2337\/dc24-2672","article-title":"Islet autoantibodies and their association with \u03b2-cell function and diabetes measures in children with acute recurrent and chronic pancreatitis","volume":"48","author":"Ginzburg","year":"2025","journal-title":"Diabetes Care"},{"issue":"1","key":"2026012101523848600_dgaf623-B24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.gtc.2024.08.002","article-title":"Risk factors and mechanisms for diabetes in pancreatitis","volume":"54","author":"Parra Villasmil","year":"2025","journal-title":"Gastroenterol Clin North Am"},{"issue":"8","key":"2026012101523848600_dgaf623-B25","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.4239\/wjd.v14.i8.1212","article-title":"Diabetes mellitus as a consequence of acute severe pancreatitis: unraveling the mystery","volume":"14","author":"Manrai","year":"2023","journal-title":"World J Diabetes"},{"issue":"8","key":"2026012101523848600_dgaf623-B26","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00535-020-01682-y","article-title":"Trajectories of glycaemia following acute pancreatitis: a prospective longitudinal cohort study with 24 months follow-up","volume":"55","author":"Bharmal","year":"2020","journal-title":"J Gastroenterol"},{"issue":"6","key":"2026012101523848600_dgaf623-B27","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.2337\/dc21-2531","article-title":"Risk of major adverse cardiovascular events, severe hypoglycemia, and all-cause mortality in postpancreatitis diabetes mellitus versus type 2 diabetes: a nationwide population-based cohort study","volume":"45","author":"Olesen","year":"2022","journal-title":"Diabetes Care"},{"issue":"10","key":"2026012101523848600_dgaf623-B28","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1007\/s00125-020-05210-8","article-title":"A tale of two pancreases: exocrine pathology and endocrine dysfunction","volume":"63","author":"Rickels","year":"2020","journal-title":"Diabetologia"},{"issue":"8","key":"2026012101523848600_dgaf623-B29","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3949\/ccjm.92a.24113","article-title":"Glucagon-like peptide-1 receptor agonists and pancreatitis: a reconcilable divorce","volume":"92","author":"Mehta","year":"2025","journal-title":"Cleve Clin J Med"},{"issue":"3","key":"2026012101523848600_dgaf623-B30","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1111\/dom.16163","article-title":"Treatment outcomes with oral anti-hyperglycaemic therapies in people with diabetes secondary to a pancreatic condition (type 3c diabetes): a population-based cohort study","volume":"27","author":"Hopkins","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"2026012101523848600_dgaf623-B31","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.3390\/jcm13102993","article-title":"Challenges of managing type 3c diabetes in the context of pancreatic resection, cancer and trauma","volume":"13","author":"Wayne","year":"2024","journal-title":"J Clin Med"},{"issue":"5","key":"2026012101523848600_dgaf623-B32","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/MOG.0000000000000754","article-title":"Distinguishing diabetes secondary to pancreatic diseases from type 2 diabetes mellitus","volume":"37","author":"Hart","year":"2021","journal-title":"Curr Opin Gastroenterol"},{"key":"2026012101523848600_dgaf623-B33","doi-asserted-by":"crossref","first-page":"1231320","DOI":"10.3389\/fphar.2023.1231320","article-title":"Risk factors for drug-related acute pancreatitis: an analysis of the FDA adverse event reporting system (FAERS)","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Pharmacol"},{"issue":"3","key":"2026012101523848600_dgaf623-B34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1053\/j.gastro.2018.05.023","article-title":"Model to determine risk of pancreatic cancer in patients with new-onset diabetes","volume":"155","author":"Sharma","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"2026012101523848600_dgaf623-B35","doi-asserted-by":"crossref","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"7","key":"2026012101523848600_dgaf623-B36","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S2468-1253(19)30416-9","article-title":"Early detection of pancreatic cancer","volume":"5","author":"Pereira","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"2026012101523848600_dgaf623-B37","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/j.gastro.2018.04.025","article-title":"Fasting blood glucose levels provide estimate of duration and progression of pancreatic cancer before diagnosis","volume":"155","author":"Sharma","year":"2018","journal-title":"Gastroenterology"},{"issue":"1","key":"2026012101523848600_dgaf623-B38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/j.gastro.2007.10.040","article-title":"Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer","volume":"134","author":"Chari","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"2026012101523848600_dgaf623-B39","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pan.2023.11.009","article-title":"Association between unstable diabetes mellitus and risk of pancreatic cancer","volume":"24","author":"Ali","year":"2024","journal-title":"Pancreatology"},{"issue":"1","key":"2026012101523848600_dgaf623-B40","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12935-024-03456-5","article-title":"The systematic role of pancreatic cancer exosomes: distant communication, liquid biopsy and future therapy","volume":"24","author":"Qin","year":"2024","journal-title":"Cancer Cell Int"},{"issue":"2-3","key":"2026012101523848600_dgaf623-B41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000085276","article-title":"Beta-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance","volume":"5","author":"Chari","year":"2005","journal-title":"Pancreatology"},{"issue":"4","key":"2026012101523848600_dgaf623-B42","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1152\/physrev.00042.2019","article-title":"Microenvironmental determinants of pancreatic cancer","volume":"100","author":"Hessmann","year":"2020","journal-title":"Physiol Rev"},{"issue":"7","key":"2026012101523848600_dgaf623-B43","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.3390\/ijms26073191","article-title":"Gene dysregulation and islet changes in PDAC-associated type 3c diabetes","volume":"26","author":"Hill","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2026012101523848600_dgaf623-B44","doi-asserted-by":"crossref","first-page":"e1489","DOI":"10.1210\/clinem\/dgz224","article-title":"Paraneoplastic \u03b2 cell dedifferentiation in nondiabetic patients with pancreatic cancer","volume":"105","author":"Wang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026012101523848600_dgaf623-B45","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1245\/s10434-012-2577-y","article-title":"Resolution of diabetes after pancreaticoduodenectomy in patients with and without pancreatic ductal cell adenocarcinoma","volume":"20","author":"Wu","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"2026012101523848600_dgaf623-B46","doi-asserted-by":"crossref","first-page":"1543112","DOI":"10.3389\/fphar.2025.1543112","article-title":"Current paradigm and futuristic vision on new-onset diabetes and pancreatic cancer research","volume":"16","author":"Moreland","year":"2025","journal-title":"Front Pharmacol"},{"issue":"5","key":"2026012101523848600_dgaf623-B47","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1210\/clinem\/dgac670","article-title":"A reduced pancreatic polypeptide response is associated with new-onset pancreatogenic diabetes versus type 2 diabetes","volume":"108","author":"Hart","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2026012101523848600_dgaf623-B48","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.pan.2023.07.001","article-title":"Risk of pancreatic cancer in people with new-onset diabetes: a Danish nationwide population-based cohort study","volume":"23","author":"Jensen","year":"2023","journal-title":"Pancreatology"},{"issue":"5","key":"2026012101523848600_dgaf623-B49","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/MPA.0b013e318220816a","article-title":"Weight loss precedes cancer-specific symptoms in pancreatic cancer-associated diabetes mellitus","volume":"40","author":"Hart","year":"2011","journal-title":"Pancreas"},{"issue":"16","key":"2026012101523848600_dgaf623-B50","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.3390\/cancers13163946","article-title":"Drug repurposing, an attractive strategy in pancreatic cancer treatment: preclinical and clinical updates","volume":"13","author":"De Lellis","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"2026012101523848600_dgaf623-B51","doi-asserted-by":"crossref","first-page":"466","DOI":"10.3390\/cancers17030466","article-title":"Exploring the role of SGLT2 inhibitors in cancer: mechanisms of action and therapeutic opportunities","volume":"17","author":"Pandey","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"5","key":"2026012101523848600_dgaf623-B52","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.2337\/db11-1109","article-title":"Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model","volume":"61","author":"Gier","year":"2012","journal-title":"Diabetes"},{"issue":"9","key":"2026012101523848600_dgaf623-B53","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.3390\/cancers16091625","article-title":"The use of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus does not increase the risk of pancreatic cancer: a U.S.-based cohort study","volume":"16","author":"Ayoub","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"7","key":"2026012101523848600_dgaf623-B54","doi-asserted-by":"crossref","first-page":"e2421305","DOI":"10.1001\/jamanetworkopen.2024.21305","article-title":"Glucagon-like peptide 1 receptor agonists and 13 obesity-associated cancers in patients with type 2 diabetes","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2026012101523848600_dgaf623-B55","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0022-3476(05)80032-0","article-title":"Pancreatic endocrine function in cystic fibrosis","volume":"118","author":"Moran","year":"1991","journal-title":"J Pediatr"},{"key":"2026012101523848600_dgaf623-B56","author":"Patient Registry"},{"issue":"8","key":"2026012101523848600_dgaf623-B57","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/pedi.13453","article-title":"ISPAD clinical practice consensus guidelines 2022: management of cystic fibrosis-related diabetes in children and adolescents","volume":"23","author":"Ode","year":"2022","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"2026012101523848600_dgaf623-B58","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jcf.2017.11.015","article-title":"Hypoglycaemia in cystic fibrosis: an analysis of a single centre adult cystic fibrosis clinic","volume":"17","author":"Armaghanian","year":"2018","journal-title":"J Cyst Fibros"},{"issue":"1","key":"2026012101523848600_dgaf623-B59","doi-asserted-by":"crossref","first-page":"R35","DOI":"10.1530\/JOE-18-0468","article-title":"Survival in a bad neighborhood: pancreatic islets in cystic fibrosis","volume":"241","author":"Norris","year":"2019","journal-title":"J Endocrinol"},{"key":"2026012101523848600_dgaf623-B60","doi-asserted-by":"crossref","first-page":"100040","DOI":"10.1016\/j.arres.2022.100040","article-title":"Oxidative stress and impaired insulin secretion in cystic fibrosis pig pancreas","volume":"5","author":"O\u2019Malley","year":"2022","journal-title":"Adv Redox Res"},{"key":"2026012101523848600_dgaf623-B61","doi-asserted-by":"crossref","first-page":"1269139","DOI":"10.3389\/fendo.2023.1269139","article-title":"Pancreas and islet morphology in cystic fibrosis: clues to the etiology of cystic fibrosis-related diabetes","volume":"14","author":"Malik","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2026012101523848600_dgaf623-B62","doi-asserted-by":"crossref","first-page":"25689","DOI":"10.1038\/s41598-024-76722-1","article-title":"Cystic fibrosis-related diabetes is associated with reduced islet protein expression of GLP-1 receptor and perturbation of cell-specific transcriptional programs","volume":"14","author":"Gharib","year":"2024","journal-title":"Sci Rep"},{"issue":"6","key":"2026012101523848600_dgaf623-B63","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2337\/dc23-0380","article-title":"Cystic fibrosis-related diabetes workshop: research priorities spanning disease pathophysiology, diagnosis, and outcomes","volume":"46","author":"Putman","year":"2023","journal-title":"Diabetes Care"},{"issue":"11","key":"2026012101523848600_dgaf623-B64","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1164\/rccm.202104-1060LE","article-title":"Cystic fibrosis-related diabetes is associated with worse lung function trajectory despite ivacaftor use","volume":"204","author":"Bengtson","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2026012101523848600_dgaf623-B65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcjd.2024.09.001","article-title":"Cystic fibrosis-related diabetes: a first Canadian clinical practice guideline","volume":"49","author":"Coriati","year":"2024","journal-title":"Can J Diabetes"},{"issue":"12","key":"2026012101523848600_dgaf623-B66","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.2337\/dc10-1768","article-title":"Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society","volume":"33","author":"Moran","year":"2010","journal-title":"Diabetes Care"},{"issue":"5","key":"2026012101523848600_dgaf623-B67","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/MPG.0000000000002482","article-title":"Diabetes mellitus in children with acute recurrent and chronic pancreatitis: data from the INternational study group of pediatric pancreatitis: in search for a CuRE cohort","volume":"69","author":"Bellin","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"2026012101523848600_dgaf623-B68","doi-asserted-by":"crossref","first-page":"e0204979","DOI":"10.1371\/journal.pone.0204979","article-title":"Prevalence of abnormal glucose metabolism in pediatric acute, acute recurrent and chronic pancreatitis","volume":"13","author":"Abu-El-Haija","year":"2018","journal-title":"PLoS One"},{"issue":"5","key":"2026012101523848600_dgaf623-B69","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1210\/clinem\/dgz102","article-title":"Genetic modifiers of cystic fibrosis-related diabetes have extensive overlap with type 2 diabetes and related traits","volume":"105","author":"Aksit","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2026012101523848600_dgaf623-B70","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2337\/diab.33.11.1112","article-title":"Glucose counterregulation in patients after pancreatectomy. Comparison with other clinical forms of diabetes","volume":"33","author":"Polonsky","year":"1984","journal-title":"Diabetes"},{"issue":"10","key":"2026012101523848600_dgaf623-B71","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamasurg.2022.3702","article-title":"Bihormonal artificial pancreas with closed-loop glucose control vs current diabetes care after total pancreatectomy: a randomized clinical trial","volume":"157","author":"van Veldhuisen","year":"2022","journal-title":"JAMA Surg"},{"issue":"4","key":"2026012101523848600_dgaf623-B72","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1210\/jc.2017-02182","article-title":"Deficient glucagon response to hypoglycemia during a mixed meal in total pancreatectomy\/islet autotransplantation recipients","volume":"103","author":"Bogachus","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2026012101523848600_dgaf623-B73","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/cen.14168","article-title":"Risk factors for development of diabetes mellitus (type 3c) after partial pancreatectomy: a systematic review","volume":"92","author":"Wu","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2026012101523848600_dgaf623-B74","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.pan.2020.04.005","article-title":"The role of total pancreatectomy with islet autotransplantation in the treatment of chronic pancreatitis: a report from the international consensus guidelines in chronic pancreatitis","volume":"20","author":"Abu-El-Haija","year":"2020","journal-title":"Pancreatology"},{"key":"2026012101523848600_dgaf623-B75","volume-title":"Endotext","author":"Unnikrishnan","year":"2000"},{"issue":"4","key":"2026012101523848600_dgaf623-B76","doi-asserted-by":"crossref","first-page":"e1455","DOI":"10.1210\/clinem\/dgab864","article-title":"Two new mutations in the CEL gene causing diabetes and hereditary pancreatitis: how to correctly identify MODY8 cases","volume":"107","author":"El Jellas","year":"2022","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf623\/65371756\/dgaf623.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf623\/65371756\/dgaf623.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaf623\/65371756\/dgaf623.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:53:06Z","timestamp":1768978386000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/111\/2\/e569\/8326770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":76,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11,18]]},"published-print":{"date-parts":[[2026,1,21]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaf623","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,11,18]]}}}